Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @sclerodermaUM
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @sclerodermaUM
-
Prikvačeni tweet
We've received very touching
#sclerodermastories from patients & family. Read them all at the link below. Please consider supporting the Michigan Medicine Scleroderma Program on#GivingBlueday 11/27/18, at https://medicine.umich.edu/dept/intmed/divisions/rheumatology/research/scleroderma-program/giving-blueday … …#medicineneedsvictors#victorsinthehouse#Rheumpic.twitter.com/8IlXwcXAoe
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Our article is published in
@jclinicalinvest Collaboration with MGH and supported by@NIAIDFunding https://www.jci.org/articles/view/131700 … 1/Cytotoxic T cells induce apoptotic death of endothelial cells in SSc 2/Cell loss driven by immune cells followed by exuberant tissue repair->fibrosisPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Dinesh Khanna proslijedio/la je Tweet
Nice article about
@sclerodermaUM research faculty Eliza Tsou and her great work sponsored by@CureArthritis ! Another example of cutting edge rheumatology investigation@UMichResearchHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Dinesh Khanna proslijedio/la je Tweet
Scholarship applications are now available for the Scleroderma Foundation's 2020 National Patient Education Conference, July 17-19, Bellevue, Wash. Instructions are on the application. Deadline is March 18. Go to http://www.scleroderma.org/scholarship and download the fillable PDF form today.pic.twitter.com/Gt4FtzR8kI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Dinesh Khanna proslijedio/la je Tweet
Read more about your 2020 CRA & AHPA Annual Scientific Meeting keynote speakers!
http://ow.ly/UKoE50xVspN
Time is running out to receive our early bird rates! Visit https://asm.rheum.ca & register now.
#BettyDiamond@sclerodermaUM@timspector@AHPAconnect#rheumatologypic.twitter.com/JvQoP4UmSE
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Digits ulcer is painful complication of
#scleroderma. Published a new DU PRO, developed as part of phase 3 program. Thanks@actelion_com on working with investigators to get this important work in public domain.https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-019-2087-4 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Dinesh Khanna proslijedio/la je Tweet
CBD isn't entirely safe. Forbes reviews evidence of hepatotoxicity, esp with the CBD-based epilepsy drug Epidiolex; in studies 5-20% had liver issues. FDA has also warned of suicidal ideation, agitation, suicide, depression, aggression & panic attackshttp://bit.ly/2ZAtOb0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Exciting work by colleagues in US, led by NIH. https://www.ncbi.nlm.nih.gov/pubmed/31871193 . immunodominant peptides of topo 1, fibrillarin, and centromere protein A are homologous to viral protein sequences from the Mimiviridae and Phycodnaviridae families, suggesting molecular mimicry.
@NIH_NIAMSHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Collaboration with Drs Murphy and Poole. Fatigue is an important clinical problem in SSc and is strongly associated with decreased participation in social roles and activities. https://www.ncbi.nlm.nih.gov/pubmed/31841268
@UMIntMed@sclerodermaHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Pathophysiology of SSc-ILD--similarities and differences from IPFpic.twitter.com/62SgWAAxGe
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our review on risk factors and biomarkers in SSc-ILD in blue journal
@ATSBlueEditor@atscommunity@UMIntMed https://www.ncbi.nlm.nih.gov/pubmed/31841044 Happy Holidays!Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Dinesh Khanna proslijedio/la je Tweet
Julia's Nine. She talks to Congress. Julia got brave at age five when her
#scleroderma was diagnosed. Her bravery took her to Washington DC to seek support for#HR3446 &#S2477. Together, we can help kids like Julia focus on their dreams, not their disease https://www.facebook.com/donate/959181184482553/?fundraiser_source=external_url …pic.twitter.com/63Gzn9Ts9y
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Presentation by Dr Roofeh from the UM Scleroderma Program. Systemic sclerosis— The first 2 years.
@UMIntMed@sclerodermahttps://www.youtube.com/watch?v=88jcGyW_gZ0 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Dinesh Khanna proslijedio/la je Tweet
Giving Blue Day is on! See below!https://twitter.com/sclerodermaUM/status/1061970415764074498 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Dinesh Khanna proslijedio/la je Tweet
We've received very touching
#sclerodermastories from patients & family. Read them all at the link below. Please consider supporting the Michigan Medicine Scleroderma Program on#GivingBlueday 11/27/18, at https://medicine.umich.edu/dept/intmed/divisions/rheumatology/research/scleroderma-program/giving-blueday … …#medicineneedsvictors#victorsinthehouse#Rheumpic.twitter.com/8IlXwcXAoe
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Giving Blueday is on December 3rd...spread the word. If you are a first time donor to the university, you can potentially double your impact with the first time donor match. Support the Scleroderma Cure Fund!
#GivingBlueday@UMIntMed A message from Sheri Hickspic.twitter.com/aWr6dPnJmlHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Giving Blueday is in one week, spread the word. If you are a first time donor to the university, you can potentially double your impact with the first time donor match. Support the Scleroderma Cure Fund!
#GivingBlueday#SclerodermaCureFund@UMIntMedpic.twitter.com/rQMpoUXBm7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
David Roofeh presenting his NIH T32 project to external advisors. Supported by
@MichiganILD@ellakaz@UMIntMed and all the experts around the globe who have supported himpic.twitter.com/B6LNEUzBXQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Dinesh Khanna proslijedio/la je Tweet
@sclerodermaUM also great to be part of this work undertaken by David Roofeh from@UMIntMed on consensus definitions in#SSc-ILD#ACR2019 and meet him in person. Great poster design and important work!pic.twitter.com/Vn7D1gfUrH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
University of Michigan Scleroderma Program leading the way through excellence in clinical care, teaching, & research